|
1
|
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth.
|
Nat Med
|
2012
|
2.71
|
|
2
|
Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression.
|
Immunity
|
2012
|
1.82
|
|
3
|
Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells.
|
PLoS One
|
2013
|
0.99
|
|
4
|
SOCS3 transactivation by PPARγ prevents IL-17-driven cancer growth.
|
Cancer Res
|
2013
|
0.97
|
|
5
|
Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
|
Biochem Pharmacol
|
2013
|
0.91
|
|
6
|
Corrigendum: The receptor NLRP3 is a transcriptional regulator of TH2 differentiation.
|
Nat Immunol
|
2015
|
0.76
|